HHS Rx Price Negotiations Could Gain Bipartisan Support, Consultant Says
Executive Summary
Congress will move to strike down the Medicare Rx law's "non-interference" provision in the next two years, former Senate Finance Committee health advisor Kathleen Means said at the Biotechnology Industry Organization's annual conference in San Francisco June 9
You may also be interested in...
Arnold & Porter beefs up pharmaceutical group
Arnold & Porter adds Daniel Kracov as partner and co-head of the pharmaceutical and medical device group and Kathleen Means as the group's non-lawyer senior policy advisor. Kracov and Means both hail from Patton Boggs; Kracov was the leader of Patton Boggs' FDA group. Means is a former Senate Finance Committee health advisor and House Ways & Means Committee staffer. She also worked in the senior executive service at the Centers for Medicare & Medicaid Services (1"The Pink Sheet" June 14, 2004, p. 25)...
Arnold & Porter beefs up pharmaceutical group
Arnold & Porter adds Daniel Kracov as partner and co-head of the pharmaceutical and medical device group and Kathleen Means as the group's non-lawyer senior policy advisor. Kracov and Means both hail from Patton Boggs; Kracov was the leader of Patton Boggs' FDA group. Means is a former Senate Finance Committee health advisor and House Ways & Means Committee staffer. She also worked in the senior executive service at the Centers for Medicare & Medicaid Services (1"The Pink Sheet" June 14, 2004, p. 25)...
Medicare Rx Course Is Clearer Following Bush Victory
President Bush's victory in the Nov. 2 election means that the Centers for Medicare & Medicaid Services will have a chance to create a stand-alone drug insurance program under Medicare